Scientists from the National Institutes of Health (NIH) in collaboration with the pharmaceutical company Sanofi have engineered a three-pronged antibody that protected monkeys from two strains of Human Immunodeficiency Virus (HIV) better than the equivalent naturally occurring antibodies.
HIV is the causal agent of acquired immunodeficiency syndrome (AIDS). It infects vital immunity-providing cells causing progressive failure of the immune system. As a consequence of their compromised immune system, patients with HIV are particularly vulnerable to opportunistic infections and cancers.
